Monday, October 24, :30 p.m. to 3:30 p.m. Regency Ballroom 3
|
|
- Norah Manning
- 5 years ago
- Views:
Transcription
1 Current Research and Practice: Patient-Centered Team-Based Care Activity Number: L04-P, 1.75 hours of CPE credit; Activity Type: A Knowledge-Based Activity Monday, October 24, :30 p.m. to 3:30 p.m. Regency Ballroom 3 Moderator: Grace Kuo, Pharm. D., Ph.D., MPH Professor of Clinical Pharmacy, Associate Dean for Strategic Planning and Program Development, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego Agenda 1:30 p.m. Clinical Effectiveness of the Improving Health of at Risk Rural Patients (IHARP) Pharmacist-Physician Collaborative Care Model Gary R. Matzke, Pharm. D., FCCP. FASN Founding Director of ACCP/ASHP/VCU Congressional Health Policy Fellow Program; Professor of Pharmacotherapy and Outcome Sciences, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 2:00 p.m. Integration of Clinical Pharmacy in a Chronic Care Management Team within an Accountable Care Organization (ACO): a report from the ACO Research Network, Services and Education (ACORN SEED) Tina Joseph, Pharm. D., BCACP Assistant Professor, Nova Southeastern University, Fort Lauderdale, Florida 2:30 p.m. A Population Health Intervention by PGY-2 Pharmacy Residents to Optimize Medication Management in Patients with Atherosclerotic Cardiovascular Disease (ASCVD) Joseph P. Vande Griend, Pharm. D., FCCP, BCPS Associate Professor, University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy & Pharmaceutical Sciences, Aurora, Colorado 3:00 p.m. Establishing a Common Language for Comprehensive Medication Management: Applying Implementation Science Methodologies to the Patient Care Process Carrie Martin Blanchard, Pharm. D. Postdoctoral Research Fellow, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina Conflict of Interest Disclosures Tina Joseph: no conflicts to disclose Grace Kuo: no conflicts to disclose Carrie Martin Blanchard: no conflicts to disclose Gary R. Matzke: no conflicts to disclose Joseph P. Vande Griend: no conflicts to disclose American College of Clinical Pharmacy 1
2 Learning Objectives 1. List benefits of patient-centered team-based care. 2. Compare and contrast delivery models of patient-centered team-based care. 3. Explain the value of a consistent model of patient-centered team-based care. 4. Define comprehensive medication management (CMM) and other terminology related to practice transformation. Self-Assessment Questions Self-assessment questions are available online at American College of Clinical Pharmacy 2
3 Practice Transformation Research Informing the Future Delivery of Healthcare: Insights from IHARP Gary R. Matzke, BS Pharm, PharmD, FCP, FCCP Professor VCU School of Pharmacy On behalf of the IHARP INVESTIGATOR TEAM Current Research and Practice: Patient-Centered Team-Based Care October 24, 2016
4 Essentials of the IHARP Care Model Ambulatory Care Patients identified by primary care provider (PCP) Provider Referral Initial enrollment interview Medication care plan and discharge medication list provided Hospital Encounter PCCP/PCP collaboration 72 hour discharge phone follow up In person comprehensive medication review Ongoing medication management Updated medication list sent to pharmacy when changes are made Read only Epic access to monitor patient s Community Pharmacy
5 Pharmacist s Intervention Identify medication related problems and propose interventions to resolve them Provide CMM and CDSM to optimize medication use and clinical outcomes Patients have scheduled visits with their primary care pharmacist Each primary care pharmacist staffs up to 4 clinics Coordination of care with hospital and community pharmacists Matzke GR, Czar MJ, Lee WT, Moczygemba LR, Harlow LD. Am J Health Syst Pharm 2016;73:e583 91
6 Patient Population Enrollment Criteria Inclusion criteria 18 years of age at enrollment Primary use of English for oral and written communication 2 chronic diseases (one of which must be asthma, CHF, DM, COPD, HTN, hyperlipidemia, or depression) 4 chronic prescription medications Have a telephone line available Exclusion criteria Terminal condition with life expectancy 6months
7 Primary Outcome Measures Clinical outcomes were assessed longitudinally from baseline to last visit and at defined time intervals. Patient, physician, and clinic staff satisfaction with IHARP were evaluated routinely. Health care services utilization of all patients for at least one year prior to and during their participation. Cost of ED and hospitalizations incurred by the Medicare patients at least one year prior to and during their participation.
8 Patient Enrollment Enrollment Total: 2,678 2,480 enrolled for at least one year Jan Feb March April May June July Aug Sept Oct Nov Dec Jan Feb March April May June July August Sept Oct Nov Dec Number Enrolled Primary Care Enrolled Hospital Enrolled
9 Patient Population Demographics IHARP PATIENTS Age 65.3 (13.0) Gender 57.4 % Female Race 87.3 % White 11.7 % Black 0.3 % Hispanic # Chronic Diseases 3.3 (1.3) Health Insurer 63.5 % Medicare 6.8 % Medicaid 17.1 % Commercial COMPARITOR PATIENTS Age 65.5 (14.2) Gender 57.9 % Female Race 87.9 % White 11.1 % Black 0.4 % Hispanic # Chronic Diseases 3.2 (1.2) Health Insurer 63.9 % Medicare 7.6 % Medicaid 16.8 % Commercial
10 Clinical Outcomes
11 Clinical Outcomes in Diabetic Patients IHARP versus Comparator IHARP PATIENTS COMPARATOR PATIENTS Clinical Measure N Baseline Value Follow up Value Mean Difference Intra group p value N Baseline Value Follow up Value Mean Difference Intra group p value Between Group p value A1c ± ± < ± ± SBP ± ± < ± ± DBP ± ± < ± ± LDL ± ± Total Cholesterol ± ± ± ± ± ±
12 Clinical Outcomes in Non Diabetic Patients IHARP versus Comparator IHARP PATIENTS COMPARATOR PATIENTS Clinical Measure N Baseline Value Follow up Value Mean Difference Intra group p value N Baseline Value Follow up Value Mean Difference Intra group p value Between Group p value SBP ± < ± ± DBP ± ± ± ± LDL ± ± Total Cholesterol ± ± ± ± ± ±
13 IHARP Diabetics and Non Diabetics with baseline values above goal Baseline versus Follow Up Outcome Measure Values All p values < SBP DBP LDL A1c x 10 Diabetic baseline Diabetic final Non Diabetic baseline Non Diabetic final
14 Comparator Diabetics and Non Diabetics with baseline values above goal Baseline versus Follow Up Outcome Measure Values All p values < SBP DBP LDL A1c x 10 Diabetic baseline Diabetic final Non Diabetic baseline Non Diabetic final
15 Difference between IHARP and Comparator Patients with baseline values above goal Mean Difference of Patients Outcome Measure Values p = p = p = P = p = p = SBP DBP LDL IHARP Diabetic Comprator Diabetic IHARP Non Diabetic Comparator Non Diabetic
16 Time Course of Changes in Clinical Values IHARP Diabetic Patients with baseline values above goal A1C X 10 OR BLOOD PRESSURE (MMHG) OR LDL (MG/DL) Baseline Baseline to 6 months 6 12 months months SBP DM DBP DM LDL DM A1c x
17 Patient Satisfaction with IHARP Program I would return to my IHARP pharmacist. N=775 I would encourage family members to consult with an IHARP pharmacist. N=775 My IHARP pharmacists helped me avoid having problems with my medications I would request that Carilion Clinic continue the IHARP program. N= Disagree Neutral Agree
18 Physician Satisfaction with IHARP Program I would like to work with pharmacists in the same way in the future I am satisfied with the collaboration with the IHARP pharmacists The IHARP program has enhanced positive outcomes for my patients The pharmacists have reduced the time I spend on medication reconcilliation
19 Lessons Learned Data collection and archiving were challenging but essential Continual monitoring of data (CQI) allowed for adjustment of procedures to facilitate achievement of desired outcomes Access to EMR data greatly facilitated continuity of care The role for a pharmacist on a primary care team is not apparent to everyone Building relationships with staff is as important as building relationships with patients Adherence is sometimes all about money
20 Lessons Learned Collaboration with community pharmacies and Carilion owned retail pharmacies a challenge Medication reconciliation process system and community wide coordination is needed Increased MAP needs recognized required changes in staffing and communication
21 Conclusions The addition of comprehensive medication and disease state management into team based PCMH resulted in significant improvements in clinical outcomes. PCMH staff, physicians, and patients expressed a high degree of satisfaction with the pharmacists contribution to the patient care team. Health services utilization was reduced and suggests a strong return on investment. The question is to whom.
22 IHARP PROJECT TEAM Leadership William Lee, DPh, MPA, FASCP Michael J. Czar, RPh, PhD Anthony R. Stavola, MD Gary R. Matzke, PharmD FCP, FCCP Leticia R. Moczygemba, PharmD, PhD Carilion Partners Michael Jeremiah, MD Charles Tarasidis, PharmD Chad Alvarez, PharmD Clinical Pharmacists Karen J. Williams, PharmD, BCPS Heidi D. Wengerd, PharmD Kelley D. Hall, PharmD Courtney P. Dickerson, PharmD Tanvi Patil, PharmD Nikisa Blevins, PharmD Ann Lucktong, PharmD, BCACP Randi Earls, PharmD IHARP Staff Kristy Cornell Christine Riddell Andrea Pierce, PharmD Della Varghese, PharmD, PhD Bhavini Kaneria, MS Samantha Marks, PharmD Alicia Johns
23 Questions PHARMACY
24 Integration of Clinical Pharmacy in a Chronic Care Management Team within an Accountable Care Organization: A report from the ACO Research Network, Services, and Education Tina Joseph, PharmD, BCACP Nova Southeastern University College of Pharmacy Fort Lauderdale, Florida October 24, 2016
25 Question 1 Which of the following is true regarding ACOs? A. Reimbursement is based on 33 quality measures B. Minimum of 5,000 Medicare beneficiaries must be assigned to the ACO C. Must have processes in place that promote patient centered care and evidence based medicine D. All of the above
26 Question 2 Which of the following condition(s) must be met to bill for CCM? A. 20 minutes of face to face contact per calendar month B. Patient must have 1+ chronic conditions expected to last at least 12 months or until the death of the patient C. Allow 24/7 access to that electronic health record (EHR) for staff to respond to urgent care needs D. All of the above
27 Question 3 Which of the following is true concerning pharmacist involvement in the multidisciplinary team? A. Pharmacists are more likely to recommend costlier drugs B. Having a pharmacist on the multidisciplinary team negates the need to select and follow guidelines C. Pharmacist involvement has been shown to reduce ER visits and hospital readmissions D. Patient and physician satisfaction tend to decrease
28 What is an ACO? Network of healthcare providers that receives reimbursement based on metrics of Quality Care, Patient Satisfaction, and Reductions in Cost of Care Centers for Medicare and Medicaid Services. Accountable Care Organizations. Jan Available at Fee for Service Payment/ACO/index.html?redirect=/ACO/. Accessed on October 6, 2016
29 ACO Shared Savings Requirements Become accountable for the care delivered Commit to a 3 year agreement Formal legal structure Establish and maintain a shared governance structure Sufficient number of primary care providers to ensure that at least 5,000 Medicare beneficiaries will be assigned to the ACO Have processes in place that promote patient centered care, evidence based medicine, care coordination, and quality and cost measures Centers for Medicare & Medicaid Services. Summary of Final Rule Provisions for Accountable Care Organizations under the Medicare Shared Savings Program April 2015 Available at fee for service payment/sharedsavingsprogram/downloads/aco_summary_factsheet_icn pdf. Accessed on October 6, 2016.
30 ACO Quality Measures ACO Quality Measures Patient/Caregiver Experience #1 7 Care Coordination/Patient Safety #8 13 Preventive Health #14 21 At risk Population #22 33 Centers for Medicare and Medicaid Services. ACO Shared Savings Program Quality Measures: Table 33 ACO Quality Measures. Available from: Fee for Service Payment/sharedsavingsprogram/Downloads/ACO Shared Savings Program Quality Measures.pdf. Accessed on October 6, 2016
31 Chronic Conditions Account for Most Spending TOTAL MEDICARE MEDICAL SPENDING MEDICARE SPENDING ON 65+ POPULATION 65+ WITH 2 OR MORE CHRONIC CONDITIONS 65+ WITH 6 OR MORE CHRONIC CONDITIONS $324 billion $261 billion $246 billion $135 billion 34 million 25 million 19 million 4 million Hoyer, Meghan. Nation s Sickest Seniors Reshape Healthcare. USA Today. Available from: costs seniors sick chronic conditions/ /. Accessed on October 6, 2016.
32 What is Chronic Care Management? 2+ chronic conditions* 20 mins nonface to face contact $42.91/ patient per month *Alzheimer s disease, arthritis, asthma, atrial fibrillation, cancer, COPD, depression, diabetes, heart failure, hypertension, ischemic heart disease, or osteoporosis American College of Physicians. Chronic care management tool kit: what practices need to do to implement and bill CCM codes 2015 Available from: Accessed on October 6, 2016.
33 Steps for Implementing CCM 1. Identify patients with 2+ chronic conditions 2. Enroll patients and sign consent forms 3. Engage patients 4. Follow up with patients 5. Practice bills Medicare
34 Accountable Care Options, LLC Network of 36 primary care physician offices located in South Florida Expansion of CCM/TOC team in medical assistant 2 paramedics 1 mental health coach 1 nurse practitioner
35 Nova Southeastern University College of Pharmacy Private, not for profit university Offers entry level Doctor of Pharmacy Program in 3 sites Fort Lauderdale, Palm Beach Gardens, and San Juan ACO Research Network, Services, and Education (ACORNSEED) Established in 2014 and composed of 5 pharmacy practice faculty, 1 clinical pharmacist, and 1 ACO fellow Purpose: Prepare students for innovative healthcare models and provide benefit to value based healthcare systems
36 CCM Team Vision: Provide optimal care of patients and work to improve ACO quality benchmark measures Daily, weekly or monthly follow up of patients Educational classes for patients that focus on chronic disease state management CCM Grand Rounds: Meeting of a multidisciplinary team on Friday morning to discuss high risk, complicated patients Goals: Promote professional development and optimal patient care practices
37 Primary Care Physician Medical Assistants Paramedics Administrative Team Patient Mental Health Counselor Pharmacists Palliative Care (DO/NP) Nurse Practitioner
38 Results: Total Cost Group (N=45) Total Costs 2015 (First 6 months) Total Costs 2016 (First 6 months) Percent Change ACO beneficiaries $775, $420, %
39 Results: Emergency Room Visits 100% 111%
40 Results: Inpatient Visits 55% 66%
41 Lessons Learned Start small and continue to build Teams do not replace the physician patient relationship, but rather enhance Communication among team members needs to be efficient Mechanisms for billing are still being evaluated Multidisciplinary training is necessary for future healthcare professionals
42 Acknowledgements Nova Southeastern University/ ACORNSEED Renee Jones, PharmD, CPh Matthew Seamon, PharmD, Esq. Genevieve Hale, PharmD, BCPS Stephanie Gernant, PharmD, MS Matthew Schneller, PharmD Cynthia Moreau, PharmD Yesenia Prados, PharmD Accountable Care Options, LLC Richard Lucibella, MHS, MBA Haidy Rodriguez Janice Del Pilar, MSEd, LMHC Melissa Sedli Joe Walsh, MAG, NRP Elizabeth Lucas, MA Leonard Hock, DO, MACOI, CMD, HMDC, FAAHPM Margaret Pizarro, ARNP
43 Question 1 Which of the following is true regarding ACOs? A. Reimbursement is based on 33 quality measures B. Minimum of 5,000 Medicare beneficiaries must be assigned to the ACO C. Must have processes in place that promote patient centered care and evidence based medicine D. All of the above
44 Question 1 Which of the following is true regarding ACOs? A. Reimbursement is based on 33 quality measures B. Minimum of 5,000 Medicare beneficiaries must be assigned to the ACO C. Must have processes in place that promote patient centered care and evidence based medicine D. All of the above
45 Question 2 Which of the following condition(s) must be met to bill for CCM? A. 20 minutes of face to face contact per calendar month B. Patient must have 1+ chronic conditions expected to last at least 12 months or until the death of the patient C. Allow 24/7 access to that electronic health record (EHR) for staff to respond to urgent care needs D. All of the above
46 Question 2 Which of the following condition(s) must be met to bill for CCM? A. 20 minutes of face to face contact per calendar month B. Patient must have 1+ chronic conditions expected to last at least 12 months or until the death of the patient C. Allow 24/7 access to that electronic health record (EHR) for staff to respond to urgent care needs D. All of the above
47 Question 3 Which of the following is true concerning pharmacist involvement in the multidisciplinary team? A. Pharmacists are more likely to recommend costlier drugs B. Having a pharmacist on the multidisciplinary team negates the need to select and follow guidelines C. Pharmacist involvement has been shown to reduce ER visits and hospital readmissions D. Patient and physician satisfaction tend to decrease
48 Question 3 Which of the following is true concerning pharmacist involvement in the multidisciplinary team? A. Pharmacists are more likely to recommend costlier drugs B. Having a pharmacist on the multidisciplinary team negates the need to select and follow guidelines C. Pharmacist involvement has been shown to reduce ER visits and hospital readmissions D. Patient and physician satisfaction tend to decrease
49 Integration of Clinical Pharmacy in a Chronic Care Management Team within an Accountable Care Organization: A report from the ACO Research Network, Services, and Education Tina Joseph, PharmD, BCACP Nova Southeastern University College of Pharmacy Fort Lauderdale, Florida October 24, 2016
50 A Population Health Intervention by PGY2 Pharmacy Residents to Optimize Medication Management in Patients with Atherosclerotic Vascular Disease (ASCVD) Joseph Vande Griend, PharmD, FCCP, BCPS, CGP Associate Professor and Assistant Director of Clinical Affairs University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences Co Authors: Michael S. Kelly, PharmD, Jessica L. Norman, PharmD Alvin B. Oung, PharmD, Sara A. Wettergreen, PharmD Joseph J. Saseen PharmD
51 Clinical Pharmacy and Family Medicine Collaboration at University of Colorado 3 pharmacist faculty, pharmacy residents 1998: A.F. Williams Family Medicine Center (Medical Residency Training Clinic) 2000: University of Colorado Hospital (Inpatient Family Medicine Service) 2011: Park Meadows Clinic 2013: Boulder Clinic 2014: Westminster Clinic* Distant from main University campus *PGY-2 Pharmacy Resident support started in 2014
52 Outlying Family Medicine Clinical Pharmacy Service Population Health approach Definition of population health Clinical pharmacist and PGY2 resident onsite ½ day weekly at each clinic with offsite support through the EHR Development of collaborative working relationship Prospective clinical pharmacy comprehensive medication management (CMM) Utilizing the CP2 Score, PGY2 residents targeted patients with ASCVD from July 2015 through December 2015 Statin therapy, diabetes, HTN, antiplatelets, vaccines Team based comprehensive medication management When medication related problems were identified, Clinical Pharmacy Consultation note was placed in EHR prior to patient appointment Provider consultation in person when available
53 Clinical Pharmacy Priority (CP2) Score CP2 Score development Programmed within the EPIC EHR using ICD 9/10 codes and patient specific data Cross section report of the upcoming week s appointments, with prioritized scores, generated each Friday Previously shown to identify patients who are most likely to have medication related problems Ongoing prospective clinical pharmacy review to prioritize patients for CMM
54 CP2 Score (range: 0-21 points) Criteria Diagnosis - Diabetes, HTN, Vascular disease - COPD, Heart failure, Depression Score 2 points each 1 point each Age (years) < 65, 65 to 75, > 75 0, 1, 2 points egfr < 45 ml/min A1c > 7.9%, > 8.9% BP > 140/90 (including average of last 3) BP > 160/100 (including average of last 3) Items on medication list < 3 3 to 5 6 to 9 > 9 1 point 1, 2 points 1 point 2 points 0 points 1 points 2 points 4 points Vande Griend JP, Saseen JS, Bislip D, et al. Prioritization of patients for comprehensive medication review by a clinical pharmacist in family medicine. J Am Board Fam Med 2015;28:
55 Justification 223 patients reviewed; 176 medication recommendations Overall Patient Demographics (n=223) Mean age 69.5 years Diabetes diagnosis 36.8% Hypertension diagnosis 75.8% Depression diagnosis 21.5% Elevated blood pressure* 6.7% Elevated A1c# 6.7% Mean number of items on medication list 12.7 items Mean CP2 Score 9 *Last BP > 140/90 and average of last 3 BP > 140/90 #Last A1c > 7.9%
56 Patient characteristics in those with and without identified medication related problems (MRPs) Characteristic Patients with MRPs Mean age (years) Diabetes diagnosis (%) HTN diagnosis (%) Depression diagnosis (%) Elevated blood pressure (%)* Elevated A1c (%)# Mean number of items on med list Mean CP2 Score *Last BP > 140/90 and average of last 3 BP > 140/90 #Last A1c > 7.9% Patients without MRPs
57 Justification Most common medication related Common recommendations problems identified Needs additional therapy (107) Vaccine (85), Statin (8), Antiplatelet (7) Blood pressure lowering (1), Antidiabetic (1) Unnecessary drug therapy (11) ER niacin not indicated (4), gemfibrozil not indicated (2), ezetimibe not indicated (2) Wrong dose (23) High potency statin needed (16), diabetes medication dose too low (4), blood pressure dose too low (3)
58 Justification Percentage of patients reviewed with at least one MRP 61% 39% At least one MRP No MRPs Percentage of recommendations implemented by provider 50% 50% Implemented Not Implemented
59 Recommendations with the highest implementation rate
60 Adaptability CMM by PGY2 Ambulatory Care residents identified MRPs in approximately 40% of patients with ASCVD The acceptance rate of recommendations was similar to those seen in previously published clinical pharmacy studies 1 9 Less than 50% acceptance: Offsite MTM service or community pharmacy utilizing fax 55% to 90% acceptance: hospital, long term care, primary care This intervention could be used by other family medicine clinics, but may be improved by using collaborative practice agreements to optimize resolution of identified MRPs 1. Fam Med. 2014; 46(5): J Am Board Fam Med. 2015; 28: J Am Pharm Assoc. 2010; 50(3): J Clin Pharm. 2012; 34(2): J Manag Care Pharm. Jun 2011;17(5): Consult Pharm. Jan 2011;26(1): Am J Geriatr Pharmacother. Mar 2007;5(1):40-47J 8. Am Pharm Assoc (2003). Nov-Dec 2008;48(6): J Am Pharm Assoc (2003). Sep-Oct 2012;52(5):
61 Significance This population health intervention improved quality of care for patients with ASCVD at three family medicine clinics Using PGY2 Ambulatory Care residents to deliver clinical pharmacy services in family medicine clinics can improve medication management for patients with ASCVD
62 Population health strategies for medication management All strategies should efficiently and effectively target the population of patients needing the benefit 8 key elements for effective collaboration 1 1) Pharmacist with clinical experience 2) Pharmacist patient relationship 3) Access to EHR 4) Patient interview by the pharmacist 5) Patient referral from PCP 6) Face to face meeting with pharmacist and PCP to discuss 7) Action plan to implement recommendations 8) Follow up 1. Drugs and Aging 2013;30:
63 Optimizing the Collaborative Working Relationship (CWR) Physician, nurses, medical assistants Trust Professional relationship Communication Access to EHR Two-way Communication CWR Patient Trust Professional relationship Communication Pharmacist
64 Ongoing initiatives Ongoing prospective medication review targeting ASCVD and other clinical metrics Hypertension metrics important within UCHealth system Last blood pressure for patients aged years Average of last 3 blood pressures Pilot program utilizing clinical pharmacist at outlying clinics Retrospective chart review to identify reasons for uncontrolled BP HTN considered a Critically Important Condition so patients with HTN have regular visits Prospective clinical pharmacist review Collaborative practice agreement and Chronic Care Management
65 Establishing a Common Language for Comprehensive Medication Management: Applying Implementation Science Methodologies to the Patient Care Process Carrie Blanchard, PharmD Post-doctoral Fellow in Implementation Science UNC Eshelman School of Pharmacy Chapel Hill, NC October 24, 2016
66 Medication Therapy Management Interventions in Outpatient Settings: A Systematic Review and Meta-analysis Evidence is insufficient for most outcomes because of inconsistency and imprecisions that stem from underlying heterogeneity in populations and interventions. MTM may reduce DTPS, nonadherence, and lower utilization and costs, but evidence inconsistent. JAMA Intern Medicine 2015.
67 Barriers to Widespread Implementation Limited understanding of the medication management intervention itself (i.e., unclear to many what it is and how one would deliver it) Limited targeting of patients most in need Wide variability and inconsistency in implementation across care settings Wide variability in outcomes Fidelity lacking in most studies (is there really no impact or is the lack of impact failure to effectively implement) Limited reimbursement to support such services in primary care
68 Research to Practice SCIENCE IMPLEMENTATION PRACTICE
69 Formula for Success Effective Innovations Effective Implementation Enabling Contexts Significant Outcomes
70 Active Implementation Frameworks (AIF) EFFECTIVE & USABLE INNOVATIONS What exactly are people saying and doing that makes things better for our intended beneficiaries? STAGES What steps lead to successful implementation? DRIVERS What critical supports are needed to make this change? What is the infrastructure? TEAMS Who takes responsibility for and helps guide the change process? IMPROVEMENT CYCLES How can we create more hospitable environments, efficiently solve problems and get better? Usable Innovations Stages Drivers Teams Cycles
71 Why Establish a Usable Innovation?
72 Is it a Usable Innovation? Fidelity Assessment Operational Definitions CMM Patient Care Process Clear Description Essential Functions
73 Developing a Common Language Stages. Common Language
74 Methods Document Review Scoping Literature Review Semistructured Interviews Vetting & Consensus Usability Testing Reviewed CMM guidelines, pharmacy curriculum material, and CMM documentation resources Comprehensive review of published work related to medication management Conducted interviews with key stakeholders Document vetted by Grant Steering Committee and practice sites Rapid cycle Plan-Do-Study-Act cycles testing of the CMM Common Language in real-world practice May-July 2016 May-August 2016 August-October 2016 September- October 2016 Forthcoming field work
75 Guiding Principles Efforts to optimize medication use through CMM take a whole-person approach and target patients who will gain the most benefit. Building a patient-centered relationship is essential to the patient care process. The pharmacist assumes responsibility for ensuring the safe, effective, appropriate, and convenient use of medications by patients. Providing continuity of care, follow-up, and clinical monitoring are key to sustaining desired outcomes. Consistent care processes enable rapid uptake and spread of CMM as it maximizes efficiencies, both for pharmacists and for integration into the larger health care team.
76 Essential Functions Collect Relevant Information Monitor and Evaluate through Follow-up Assess the Information Implement the Care Plan Develop the Care Plan
77 Operational Definitions Essential Function: Implement the Care Plan Review the care plan with the patient and assure understanding and agreement. Implement recommendations (the pharmacist), where appropriate. Communicate the care plan to the rest of the care team, indicating where implementation of the plan is required by a member of the team. Communicate instructions for follow up with the patient. Document all drug therapy problems. Document the encounter and plan. Coordinate with other providers to ensure that patient follow-up and future encounters are aligned with the patient s medical and medication-related needs. Arrange follow-up in a time frame that is clinically appropriate for the specific patient, the medical conditions being monitored, and the drug therapy being taken. This will vary with each patient.
78 Operational Definitions Revisit the medical record to obtain updates on the patient s clinical status and achievement of clinical goals. Essential Function: Monitor and Evaluate through patient follow-up Conduct ongoing assessments (whether face-to-face or via phone) and refine care plan to optimize medication therapy and ensure that individual goals are achieved. Reassess the patient to determine if any new drug therapy problems have developed. Document the identification of new drug therapy problems and the resolution of previously identified drug therapy problems. Repeat the essential functions of CMM to ensure consistency in process and continuity of care.
79 Next Steps Incorporate feedback from clinical pharmacists at sites Complete 1:1 interviews with select clinical pharmacists Finalize the Common Language document and distribute to all sites Develop fidelity assessment tool Conduct usability testing (Plan-Do-Study-Act cycles) Refine Common Language document over time, as needed
80 A special thank you to ACCP and the ACCP Research Institute!
Practice Transformation Research Informing the Future Delivery of Healthcare: Insights from IHARP
Practice Transformation Research Informing the Future Delivery of Healthcare: Insights from IHARP William T. Lee, BSPharm, MPA, FASCP Pharmacy System Director, Carilion Medical Center Gary R. Matzke, BS
More informationComprehensive Medication Management (CMM) for Hypertension Patients: Driving Value and Sustainability
Comprehensive Medication Management (CMM) for Hypertension Patients: Driving Value and Sustainability Steven W. Chen PharmD, FASHP, FCSHP, FNAP Associate Dean for Clinical Affairs chens@usc.edu, 323-206-0427
More informationFinancial Models for Clinical Pharmacy Integration
Financial Models for Clinical Pharmacy Integration Todd J. Lessley, MPH, RN, BSN Accountable Care Manager Salud Family Health Centers Gina D. Moore, PharmD, MBA Assistant Dean for Clinical and Professional
More informationCOLLABORATIVE PRACTICE SUCCESSES IN PRIMARY CARE
COLLABORATIVE PRACTICE SUCCESSES IN PRIMARY CARE KPhA Annual Meeting September 7, 2014 Tiffany R. Shin, PharmD, BCACP Lyndsey N. Hogg, PharmD, BCACP Objectives Describe basic concepts of collaborative
More informationExpansion of Pharmacy Services within Patient Centered Medical Homes. Jeremy Thomas, PharmD Associate Professor Department Pharmacy Practice
Expansion of Pharmacy Services within Patient Centered Medical Homes Jeremy Thomas, PharmD Associate Professor Department Pharmacy Practice What is a Patient Centered Medical Home (PCMH)? "an approach
More informationEvolving Roles of Pharmacists: Integrating Medication Management Services
Evolving Roles of Pharmacists: Integrating Management Services Marie Smith, PharmD, FNAP Palmer Professor and Assistant Dean, Practice and Policy Partnerships UCONN School of Pharmacy (marie.smith@uconn.edu)
More informationPRISM Collaborative: Transforming the Future of Pharmacy PeRformance Improvement for Safe Medication Management
PRISM Collaborative: Transforming the Future of Pharmacy PeRformance Improvement for Safe Medication Management Mission: To improve the health of the people of Connecticut through safe and effective medication
More informationdiabetes care and quality improvement in our practice
The Multidisciplinary Team: The key to successful planned diabetes care and quality improvement in our practice Robb Malone, PharmD UNC General Internal Medicine January 20, 2009 Objectives Review the
More informationPCMH to ACO: Carilion Clinic s Journey
PCMH to ACO: Carilion Clinic s Journey Michael P. Jeremiah, MD, FAAFP Chair, Department of Family and Community Medicine Carilion Clinic and the Virginia Tech-Carilion School of Medicine Patient-Centered
More informationPatient Centered Medical Home: Transforming Primary Care in Massachusetts
Patient Centered Medical Home: Transforming Primary Care in Massachusetts Judith Steinberg, MD, MPH Deputy Chief Medical Officer Commonwealth Medicine UMass Medical School Agenda Overview of Patient Centered
More informationMonday, October 24, :15 a.m. to 10:45 a.m. Great Halls 1 & 2
Expanding Pharmacy Impact: Transitional Care Management and Chronic Care Management Activity Number: 0217-0000-16-1118-L04-P 1.50 hours of CPE credit; Activity Type: A Knowledge-Based Activity Monday,
More informationClinical Webinar: Integrated Pharmacy
Clinical Webinar: Integrated Pharmacy Benjamin Gross, Pharm D, MBA, BCPS, BCACP, CDE, BC ADM, ASH CHC Associate Professor Director of Residency Programs Lipscomb University College of Pharmacy Objectives
More informationTransitionRx: Impact of a Community Pharmacy Post-Discharge Medication Therapy Management Program on Hospital Readmission Rate
TransitionRx: Impact of a Community Pharmacy Post-Discharge Medication Therapy Management Program on Hospital Readmission Rate Heidi Luder, PharmD, MS, BCACP Assistant Professor of Pharmacy Practice University
More informationHypertension Best Practices Symposium Sponsored by AMGA and Daiichi Sankyo, Inc.
Hypertension Best Practices Symposium Sponsored by AMGA and Daiichi Sankyo, Inc. October 13-15, 15, 2010 Scottsdale, AZ Kaiser Permanente of the Mid-Atlantic States (KPMAS) 1 KPMAS Medical Group Profile
More informationPerformance Measurement of a Pharmacist-Directed Anticoagulation Management Service
Hospital Pharmacy Volume 36, Number 11, pp 1164 1169 2001 Facts and Comparisons PEER-REVIEWED ARTICLE Performance Measurement of a Pharmacist-Directed Anticoagulation Management Service Jon C. Schommer,
More informationBilling for Pharmacist Collaborative Patient Care Services
3/9/15 SCSHP 15 Annual Meeting Disclosure Billing for Pharmacist Collaborative Patient Care Services Bob Davis, PharmD, FAPhA Professor, Kennedy Pharmacy Innovation Center, University of South Carolina
More informationMedication Management Center
Academic-Community Partnership to Implement Medication Therapy Management (MTM) Services in Rural Communities to Improve Adherence to Preventative Health Guidelines for Patients with Diabetes and/or Hypertension
More informationLessons for Community Pharmacy from the USC / AltaMed CMMI Healthcare Innovation Award (Round 1)
Lessons for Community Pharmacy from the USC / AltaMed CMMI Healthcare Innovation Award (Round 1) Steven W. Chen PharmD, FASHP, FCSHP, FNAP Associate Professor and Chair Titus Family Department of Clinical
More information7/7/17. Value and Quality in Health Care. Kevin Shah, MD MBA. Overview of Quality. Define. Measure. Improve
Value and Quality in Health Care Kevin Shah, MD MBA 1 Overview of Quality Define Measure 2 1 Define Health care reform is transitioning financing from volume to value based reimbursement Today Fee for
More informationManaging Risk Through Population Health Initiatives
Managing Risk Through Health Initiatives Vicki DeBaca, DNS, RN Vice President, Health & Provider Services Sharp Rees-Stealy Medical Centers 1 Sharp Rees-Stealy Medical Centers San Diego s Multi-Specialty
More informationTHE BEST OF TIMES: PHARMACY IN AN ERA OF
OBJECTIVES THE BEST OF TIMES: PHARMACY IN AN ERA OF ACCOUNTABLE CARE Toni Fera, BS, PharmD October 17, 2014 1. Describe the role of pharmacists in accountable care organizations (ACO). 2. List four key
More informationH2H Mind Your Meds "Challenge. Webinar #3- Lessons Learned Wednesday, April 18, :00 pm 3:00 pm ET. Welcome
H2H Mind Your Meds "Challenge Webinar #3- Lessons Learned Wednesday, April 18, 2012 2:00 pm 3:00 pm ET 1 Welcome Take Home Messages Understand how to implement the Mind Your Meds strategies and tools in
More informationAccountable Care and the Laboratory Value Proposition. Les Duncan Director of Operations Highmark Health - Home and Community Services
Accountable Care and the Laboratory Value Proposition Les Duncan Director of Operations Highmark Health - Home and Community Services Agenda The Goals and Status of Delivery System Reform and Alternative
More informationUtilizing a Pharmacist and Outpatient Pharmacy in Transitions of Care to Reduce Readmission Rates. Disclosures. Learning Objectives
Utilizing a Pharmacist and Outpatient Pharmacy in Transitions of Care to Reduce Readmission Rates. Disclosures Rupal Mansukhani declares grant support from the Foundation for. Rupal Mansukhani, Pharm.D.
More informationMedication Therapy Management
Medication Therapy Management Presented by Sylvia Saade, PharmD Ghada Khoury, Pharm D, BCACP Objectives Describe the components of medication therapy management (MTM) programs Discuss the needs of MTM
More informationImproving Health Outcome Measures and Medication Safety through Integration of Clinical Pharmacy Services
Improving Health Outcome Measures and Medication Safety through Integration of Clinical Pharmacy Services Steven Chen, Pharm.D., FASHP Associate Professor Director, PGY1 Residency Program in Primary Care
More informationConnecticut Department of Public Health and Community Pharmacists Medication Management Services
Connecticut Department of Public Health and Community Pharmacists Medication Management Services MODERATOR: Marie Smith, PharmD Palmer Professor and Assistant Dean, Practice and Public Policy Partnerships,
More information7:30 a.m. 8:05 a.m. Welcome/Introductions and Tips for Success
AGENDA SATURDAY, DECEMBER 2 ND 7:30 a.m. 8:05 a.m. Welcome/Introductions and Tips for Success 8:05 a.m. 9:35 a.m. Complex Pediatric Asthma Case Kyana D. Stewart, Pharm.D., M.S., BCPS ACPE Number: 0204-0000-17-969-L01-P
More informationCardiovascular Disease Prevention and Control: Interventions Engaging Community Health Workers
Cardiovascular Disease Prevention and Control: Interventions Engaging Community Health Workers Community Preventive Services Task Force Finding and Rationale Statement Ratified March 2015 Table of Contents
More informationMedication Management Services in Connecticut
Medication Management Services in Connecticut Connecticut Department of Public Health, UConn School of Pharmacy and Community Pharmacies Mehul Dalal, MD, MSc, MHS - Chronic Disease Director, CT Department
More informationDisclosures. Platforms for Performance: Clinical Dashboards to Improve Quality and Safety. Learning Objectives
Platforms for Performance: Clinical Dashboards to Improve Quality and Safety Disclosures The program chair and presenters for this continuing pharmacy education activity report no relevant financial relationships.
More informationHouseCalls Objectives
Overview Agenda Overview Objectives Background Case studies Member Experience Primary Care Provider Experience Referrals and Follow-up Influence on Centers for Medicare & Medicaid Services (CMS) Star Ratings
More informationPharmacy s Role in Decreasing Hospital Readmissions
Pharmacy s Role in Decreasing Hospital Readmissions ACPE UAN 107-000-11-004-L04-P & 107-000-11-004-L04-T Activity Type: Knowledge-Based 0.15 CEU/1.5 Hr Program Objectives for Pharmacists: Upon completion
More informationUniversity of Cincinnati Patient Centered Medical Home Leadership Decisions
University of Cincinnati Patient Centered Medical Home Leadership Decisions Eric J. Warm M.D., F.A.C.P. Program Director, Internal Medicine Associate Professor of Medicine University of Cincinnati College
More informationTransitions of Care. Objectives 1/6/2016. Roman Digilio, PharmD PGY1 Resident West Kendall Baptist Hospital. The author has nothing to disclose.
Transitions of Care Roman Digilio, PharmD PGY1 Resident West Kendall Baptist Hospital 1 The author has nothing to disclose. 2 Objectives Discuss current healthcare trends and the need for pharmacists in
More informationE1. STUDENTS IN-NO-VA-TION 10:45-11:45AM
E1. STUDENTS IN-NO-VA-TION 10:45-11:45AM Speaker: Randy P. McDonough, PharmD, MS, CGP, BCPS, FAPhA, is Co-owner of Towncrest and Towncrest Compounding Pharmacies in Iowa City and Solon Towncrest Pharmacy
More informationUnited Medical ACO Participation Criteria
United Medical ACO Participation Criteria Items Requiring Practice Reporting 1) Submission of Reports: Practices must report A,B, and C to UMACO A. Thirty-four ACO Quality Measures -See Appendix A B. Average
More informationDisclosures. Learning Objectives 4/26/2017. Impact of a Pilot Ambulatory Care Pharmacist in a Family Practice Clinic
Impact of a Pilot Ambulatory Care Pharmacist in a Family Practice Clinic Taylor Sandvick, PharmD, PGY1 Pharmacy Resident St. Peter s Hospital, Helena, MT April 29, 2017 Disclosures 2 Financial: Nothing
More informationExhibit 1. Medicare Shared Savings Program: Year 1 Performance of Participating Accountable Care Organizations (2013)
Exhibit 1. Medicare Shared Savings Program: Year 1 Performance of Participating Accountable Care Organizations (2013) 24 percent (52 ACOs) earned shared savings bonus 27 percent (60 ACOs) reduced spending,
More informationMedicare Advantage Star Ratings
Medicare Advantage Star Ratings December 2017 The Star Rating System measures how well Medicare Advantage (MA) and its prescription drug plans perform for consumers. As an integrated health system, Presbyterian
More informationPPMI in a Community Teaching Hospital
Presentation Objectives PPMI in a Community Teaching Targeting VBP and ACO metrics Pharmacist Objective: List ACO metrics that pharmacists can share accountability to achieve targets Technician Objective:
More informationTransition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit, MI
Transition of Care Practices Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit, MI Objectives Pharmacist 1. Describe transition of care opportunities 2. Explain ways to use pharmacist extenders
More informationAdministrative Update: How to Implement Discharge Pharmacy Services (DPS) Objectives
Administrative Update: How to Implement Discharge Pharmacy Services (DPS) Morgan Pendleton, PharmD, BCOP Hematology/Oncology Clinical Pharmacist Wake Forest Baptist Health Objectives Evaluate the need
More informationImproving Primary Care Medication Patient Safety: System-level Medication Adherence Issues
Improving Primary Care Medication Patient Safety: System-level Medication Adherence Issues Marie Smith, PharmD Professor and Asst. Dean, Practice and Public Policy Partnerships Meg Mello Moniz, PharmD
More informationMedication Adherence
Medication Adherence Robert DiGregorio, PharmD, FNAP, BCACP Professor (Long Island University) Sr. Director, Pharmacy & Pharmacotherapy Services (TBHC) Chief, Pharmacotherapy Department of Internal Medicine
More informationUniversity of Utah PGY-1 Pharmacy Practice Primary Care: Ambulatory I & II Rotation Salt Lake City, Utah
University of Utah PGY-1 Pharmacy Practice Primary Care: Ambulatory I & II Rotation Salt Lake City, Utah Primary Preceptors: Redwood Health Center Macheala Jacquez, PharmD, BCACP; Megan Lowe, PharmD, BCACP;
More informationMedicare Part D Member Satisfaction of the Comprehensive Medication Review. Katie Neff-Golub, PharmD, CGP, CPh WellCare Health Plans
Medicare Part D Member Satisfaction of the Comprehensive Medication Review Katie Neff-Golub, PharmD, CGP, CPh WellCare Health Plans 1 Disclosure Statement Disclosure Statement: These individuals have the
More informationImproving Quality Outcomes in a Risk-Based World: A Davies Story Session #100, March 7, 2018
Improving Quality Outcomes in a Risk-Based World: A Davies Story Session #100, March 7, 2018 David Cloyed, MS, RN-BC, Applications Manager, Nebraska Medicine Tammy Winterboer, PharmD, BCPS, Director, Clinical
More informationMTM Performance & Impact On Star Ratings 2016 & Beyond - OutcomesMTM Overview
MTM Performance & Impact On Star Ratings 2016 & Beyond - OutcomesMTM Overview Today s Speaker Dan Rodriguez, RPh, BPharm Sr. Associate Network Performance OutcomesMTM Learning Objectives - Define Medication
More informationOriginal Research PRACTICE-BASED RESEARCH. University Wexner Medical Center
Evaluation of provider documentation of medication management in a Patient-Centered Medical Home (PCMH) Trang T. Nguyen, PharmD 1 ; Bella H Mehta, PharmD, FAPhA 2 ; Jennifer L. Rodis, PharmD, BCPS 2 ;
More informationPharmacy Services Providing Value In An Accountable Care Organization
Presentation Outline Pharmacy Services Providing Value In An Accountable Care Organization The Fairview i Experience Pamela Phelps, Pharm.D., FASHP Director, Clinical Pharmacy Services Fairview Health
More informationFebruary 2007 ACP, AAFP, AAP, AOA joint statement
Patient Centered Medical Home in a Safety Net Community Health Clinic: The T Transformation f i off Eastside Adult Clinic Nicole Joseph, MD Denver Health GIM Grand G dr Rounds d February 7, 2012 OBJECTIVES
More informationHow Does This Fit into the Provisions of the Affordable Care Act? The goals are aligned
Background April 2012 The Federal Centers for Medicare and Medicaid Services (CMS) approved 3 NJ Accountable Care Organizations (ACOs) to participate in the Medicare Shared Savings Program Accountable
More information7:30 a.m. 8:05 a.m. Welcome/Introductions and Tips for Success Stuart T. Haines, Pharm.D., BCPS, BCACP, BC-ADM
AGENDA SATURDAY, JUNE 11TH 7:30 a.m. 8:05 a.m. Welcome/Introductions and Tips for Success Stuart T. Haines, Pharm.D., BCPS, BCACP, BC-ADM 8:05 a.m. 8:50 a.m. Complex Case: Pediatric Patient Seena Haines,
More informationResearch Opportunities to Improve Hypertension Control
Research Opportunities to Improve Hypertension Control Barry L. Carter, Pharm.D., FCCP, FAHA, FASH The Patrick E. Keefe Professor in Pharmacy Department of Pharmacy Practice and Science College of Pharmacy
More informationExpanding Your Pharmacist Team
CALIFORNIA QUALITY COLLABORATIVE CHANGE PACKAGE Expanding Your Pharmacist Team Improving Medication Adherence and Beyond August 2017 TABLE OF CONTENTS Introduction and Purpose 1 The CQC Approach to Addressing
More informationWELCOME. Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association
WHAT IS MACRA? WELCOME Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association WELCOME Anthony Pudlo, PharmD, MBA, BCACP Vice President of Professional Affairs Iowa Pharmacy Association
More informationPopulation Health or Single-payer The future is in our hands. Robert J. Margolis, MD
Population Health or Single-payer The future is in our hands Robert J. Margolis, MD Today s problems Interim steps Population health Alternatives Conclusions Outline $3,000,000,000,000 $1,000,000,000,000
More informationThe Science of Medication Adherence P R E S E N T E D T O L E A D I N G A G E W A S H I N G T O N J U N E 6 TH,
The Science of Medication Adherence P R E S E N T E D T O L E A D I N G A G E W A S H I N G T O N J U N E 6 TH, 2 0 1 2 Why are we talking about adherence? Nonadherence Waste $258.3 Billion 62% Adherence
More informationTransition from Hospital to Home: Importance of Medication Education and Reconciliation
Transition from Hospital to Home: Importance of Medication Education and Reconciliation Julie Baron, PharmD, CGP, BCACP/Clinical Pharmacy Specialist/Kaiser Permanente Lindsay Salsburg, PharmD, BCACP/Clinical
More informationEmerging Opportunities: Pharmacy Care. NACDS Total Store Expo August 20, 2017
Emerging Opportunities: Pharmacy Care NACDS Total Store Expo August 20, 2017 Presentation Objectives Current value based healthcare landscape Medication management as a critical component to achieve value
More informationCardiovascular Disease Prevention: Team-Based Care to Improve Blood Pressure Control
Cardiovascular Disease Prevention: Team-Based Care to Improve Blood Pressure Control Task Force Finding and Rationale Statement Table of Contents Intervention Definition... 2 Task Force Finding... 2 Rationale...
More informationTransforming Healthcare Delivery, the Challenges for Behavioral Health
Transforming Healthcare Delivery, the Challenges for Behavioral Health Presented by: M.T.M. Services, LLC P. O. Box 1027, Holly Springs, NC 27540 Phone: 919-434-3709 Fax: 919-773-8141 E-mail: mtmserve@aol.com
More informationPromoting Interoperability Performance Category Fact Sheet
Promoting Interoperability Fact Sheet Health Services Advisory Group (HSAG) provides this eight-page fact sheet to help providers with understanding Activities that are eligible for the Promoting Interoperability
More informationCVD Prevention Takes a Team. Ed Havranek, MD Denver Health University of Colorado
CVD Prevention Takes a Team Ed Havranek, MD Denver Health University of Colorado CVD Prevention Potential Impact Modality # RCTs Outcome RR Aspirin 1 10 CV events 0.94 (0.88 0.99) BP control 2 68 All-cause
More informationThe Patient Care Process for Delivering Comprehensive Medication Management (CMM)
The Patient Care Process for Delivering Comprehensive Medication Management (CMM) Optimizing Medication Use in Patient-Centered, Team-Based Care Settings Acknowledgements Funding for this research was
More informationQuality Measurement, Population Health and Payment Reform
Quality Measurement, Population Health and Payment Reform The Move from Volume to Value Dale W. Bratzler, DO, MPH, FACOI, FIDSA Professor, Colleges of Medicine and Public Health Associate Dean, College
More informationArkansas Blue Cross and Blue Shield Patient Centered Medical Home Provider Manual
Arkansas Blue Cross and Blue Shield Patient Centered Medical Home Provider Manual 2016 This document is a guide to the 2016 Arkansas Blue Cross and Blue Shield Patient-Centered Medical Home program (Arkansas
More information2015 Annual Convention
2015 Annual Convention Date: Tuesday, October 13, 2015 Time: 8:00 am 9:30 am Location: Gaylord National Harbor Resort and Convention Center, National Harbor 10 Title: Activity Type: Speaker: Opportunities
More informationMeasuring High Performers and Assessing Readiness to Change Looking Beyond the Lamppost
Measuring High Performers and Assessing Readiness to Change Looking Beyond the Lamppost Mathematica Policy Research Washington, DC November 19, 2014 Moderator Timothy Lake Director of Health Research,
More informationCOMPASS Workflow & Core Elements
COMPASS Workflow & Core Elements Care of Mental, Physical, and Substance use Syndromes! The project described was supported by Grant Number 1C1CMS331048-01-00 from the Department of Health and Human Services,
More informationMedication Management of Chronic Diseases in a Medical Home Model: CMS Medicaid Transformation Project
Medication Management of Chronic Diseases in a Medical Home Model: CMS Medicaid Transformation Project Marie Smith, PharmD University of Connecticut School of Pharmacy Marghie Giuliano, RPh, CAE CT Pharmacists
More informationUsing EHRs and Case Management to Improve Patient Care and Population Health
Using EHRs and Case Management to Improve Patient Care and Population Health Session #211, February 22, 2017 Thomas Schiller, MD and Jennifer Kuroda, SwedishAmerican Health System A Division of UW 1 Speaker
More informationInnovative Reimbursement Models Value-Based Insurance Design and the Medical Home En Route to an ACO Model
Innovative Reimbursement Models Value-Based Insurance Design and the Medical Home En Route to an ACO Model Mary Ellen Benzik,MD PCPCC Conference March 14, 2011 Community Collaboration to Transform Health
More informationInsights into Pharmacist Provided MTM Services-Present and Future
Insights into Pharmacist Provided MTM Services-Present and Future Anne Burns, RPh Vice President, Professional Affairs American Pharmacists Association Learning Objectives Describe the scope of MTM service
More informationPresenter Disclosure
Improving Transitions from the Hospital to Community Settings IHI National Forum Learning Lab Sunday, December 8, 2013 Presenter Disclosure MaryAnne Elma, MPH Quality Implementation and Innovations Director
More informationImproving Clinical Outcomes
Improving clinical outcomes and reducing health care costs under the Affordable Care Act - are enhanced medication management strategies part of the solution? Sandra L. Baldinger, Pharm.D., M.S. Kenneth
More informationDecreasing Medical. Costs. Are your members listening to you? PRESENTED BY: September 22, 2016
Decreasing Medical Costs Are your members listening to you? PRESENTED BY: Aaron Crowell, Executive Vice President, MTM, Inc. Gary Jacobs, Executive Vice President, CareCentrix Dan Masciopinto, SVP of Product,
More information2019 Quality Improvement Program Description Overview
2019 Quality Improvement Program Description Overview Introduction Eon/Clear Spring s Quality Improvement (QI) program guides the company s activities to improve care and treatment for the member s we
More informationACOs: California Style
ACOs: California Style ACO Congress John E. Jenrette, M.D. Chief Executive Officer Sharp Community Medical Group November 2, 2011 California Style California Style A CO California Style California Style
More informationAssessing pharmacist-led annual wellness visits: Interventions made and patient and physician satisfaction
EXPERIENCE Assessing pharmacist-led annual wellness visits: Interventions made and patient and physician satisfaction Courtenay Gilmore Wilson, Irene Park, Susan E. Sutherland, and Lisa Ray Abstract Objectives:
More informationTransforming to Value: One Way Forward
Transforming to Value: One Way Forward Intermountain Healthcare s Value-Based Reimbursement and Change Management Strategy Mark Briesacher, MD Senior Administrative Medical Director Intermountain Medical
More informationExecutive Summary: Davies Ambulatory Award Community Health Organization (CHO)
Davies Ambulatory Award Community Health Organization (CHO) Name of Applicant Organization: Community Health Centers, Inc. Organization s Address: 110 S. Woodland St. Winter Garden, Florida 34787 Submitter
More informationPharmacists Improve Care Through Team Collaboration
Pharmacists Improve Care Through Team Collaboration Trista Pfeiffenberger, PharmD, MS Director, Network Pharmacy Programs Community Care of North Carolina Disclosure and Conflict of Interest I am an employee
More informationAmbulatory Care Practice Trends and Opportunities in Pharmacy
Ambulatory Care Practice Trends and Opportunities in Pharmacy David Chen, R.Ph., M.B.A. Senior Director Section of Pharmacy Practice Managers ASHP Objectives Describe trends in health system pharmacy reported
More informationGetting Ready for the Maryland Primary Care Program
Getting Ready for the Maryland Primary Care Program Presentation to Maryland Academy of Nutrition and Dietetics March 19, 2018 Maryland Department of Health All-Payer Model: Performance to Date Performance
More informationUsing Data for Proactive Patient Population Management
Using Data for Proactive Patient Population Management Kate Lichtenberg, DO, MPH, FAAFP October 16, 2013 Topics Review population based care Understand the use of registries Harnessing the power of EHRs
More informationBreaking Down Silos of Care: Integration of Social Support Services with Health Care Delivery
Breaking Down Silos of Care: Integration of Social Support Services with Health Care Delivery Betty Shephard Lead VP, Care Management HealthCare Partners National Health Policy Forum October 19, 2012 HCP
More informationBrittany Turner, 2015 PharmD Candidate 1 Justin Campbell, PharmD 2 Katie McKinney, PharmD, MS, BCPS 2
Discharge Medication Concierge Program: A pilot project in heart failure to reduce readmission rates, improve patient satisfaction, and increase pharmacy business metrics Brittany Turner, 2015 PharmD Candidate
More informationPeripheral Arterial Disease: Application of the Chronic Care Model. Marge Lovell RN CCRC BEd MEd London Health Sciences Centre London, Ontario
Peripheral Arterial Disease: Application of the Chronic Care Model Marge Lovell RN CCRC BEd MEd London Health Sciences Centre London, Ontario Objectives Provide brief overview of PAD Describe the Chronic
More informationGoals & Challenges for Outpatient Quality Directors. Quality HealthCare Consulting, LLC CEO: Jennifer O'Donnell, MHA, PCMH-CCE
Goals & Challenges for Outpatient Quality Directors Quality HealthCare Consulting, LLC CEO: Jennifer O'Donnell, MHA, PCMH-CCE Objectives Learn a practical way for Quality Directors to align Quality Measures
More informationVHA Transformation to a Patient Centered Medical Home Model of Care
VHA Transformation to a Patient Centered Medical Home Model of Care Joanne M. Shear MS, FNP-BC VHA Primary Care Clinical Program Manager Office of Primary Care Operations & Policy Washington, DC Joanne.shear@va.gov
More informationEnhancing E Prescribing and Medication Adherence in the CT Medicaid Population
Enhancing E Prescribing and Medication Adherence in the CT Medicaid Population Marie Smith, PharmD UConn School of Pharmacy Marghie Giuliano, RPh, CAE CT Pharmacists Association 4th National Medicaid Congress
More informationThe PCMH St Joseph s Experience
The PCMH St Joseph s Experience Priya Radhakrishnan, MD Roshni Kundranda, MD, MSPH Binh Doung, DO Jenni Schroeder, RN, BSN ACP Regional Meeting Tucson, 2013 Disclosure No financial conflicts of interest
More informationConflict of Interest. Objectives. The Solution. The Need. Reaching for the Stars Advanced Roles for Pharmacy Technicians.
8/14/2014 Reaching for the Stars Advanced Roles for Pharmacy Conflict of Interest No conflicts of interest to disclose Informatics Bryan Shaw, Pharm.D. PGY-1 Non-Traditional Resident Northwestern Memorial
More informationThe Pharmacist Patient Care Process: Implications for Preceptors And Student- Interns
Objectives The Pharmacist Patient Care Process: Implications for Preceptors And Student- Interns Define the Joint Commission of Pharmacy Practitioners (JCPP) Pharmacist Patient Care Process (PPCP) and
More informationAbout the National Standards for CYSHCN
National Standards for Systems of Care for Children and Youth with Special Health Care Needs: Crosswalk to National Committee for Quality Assurance Primary Care Medical Home Recognition Standards Kate
More informationTransition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit
Transition of Care Practices Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit Henry Ford Hospital Detroit Transition of Care (TOC) Services Introduction to Pharmacy Services Pharmacy Transition
More informationInnovative Ways of Achieving The Triple Aim: Lessons from a Rural Community Health System
Innovative Ways of Achieving The Triple Aim: Lessons from a Rural Community Health System Roxanne Elliott, MS Policy Director FirstHealth of the Carolinas Goals For Today Review scope of project Integrate
More informationPPS Performance and Outcome Measures: Additional Resources
PPS Performance and Outcome Measures: PPS Performance and Outcome Measures: This document includes supplemental resources to the content on PPS Performance and Outcome Measures presented at the December
More information